Ascendis Pharma A/S

ASND

$220.99

Name : Ascendis Pharma A/S

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $13,502,082,048.00

EPSttm : -4.44

Ascendis Pharma A/S

$220.99

8.12%

$16.59

Float Short %

5.9

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

1.46

EPS Last/This Y

4.32

EPS This/Next Y

6.54

Price

204.51

Target Price

255.17

Analyst Recom

Performance Q

5.32

Relative Volume

2.38

Beta

0.44

Ticker: ASND

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	ASND	205.21	0.43	1.18	5750
2025-10-21	ASND	200.39	0.47	0.96	6277
2025-10-22	ASND	202.98	0.47	0.21	6278
2025-10-23	ASND	201.27	0.47	0.56	6324
2025-10-24	ASND	201.87	0.47	0.11	6337
2025-10-27	ASND	203.18	0.47	0.18	6363
2025-10-28	ASND	206.54	0.47	0.91	6395
2025-10-29	ASND	205.88	0.47	0.33	6407
2025-10-30	ASND	203.63	0.47	0.00	6410
2025-10-31	ASND	201.46	0.47	14.18	6442
2025-11-03	ASND	201.03	0.50	0.68	6606
2025-11-04	ASND	208.35	0.50	0.42	6640
2025-11-05	ASND	197.27	0.50	0.35	6655
2025-11-06	ASND	199.52	0.50	0.08	6724
2025-11-07	ASND	197.7	0.50	6.68	6723
2025-11-10	ASND	195.95	0.53	8.88	6850
2025-11-11	ASND	200.84	0.52	0.20	6819
2025-11-12	ASND	200.09	0.49	0.24	7239
2025-11-13	ASND	206.63	0.47	0.20	8184
2025-11-14	ASND	204.4	0.45	0.27	10073
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	ASND	205.21	85.0	418.5	-2.51
2025-10-21	ASND	200.32	85.0	418.7	-2.51
2025-10-22	ASND	202.70	86.9	425.6	-2.39
2025-10-23	ASND	201.07	86.9	421.8	-2.39
2025-10-24	ASND	201.76	86.9	424.1	-2.39
2025-10-27	ASND	203.15	86.9	424.3	-2.39
2025-10-28	ASND	205.91	86.9	425.8	-2.39
2025-10-29	ASND	205.60	86.9	422.7	-2.39
2025-10-30	ASND	203.71	90.8	420.7	-2.21
2025-10-31	ASND	201.60	90.8	420.9	-2.21
2025-11-03	ASND	201.04	90.8	422.3	-2.21
2025-11-04	ASND	208.30	90.8	430.1	-2.21
2025-11-05	ASND	197.11	90.8	411.6	-2.21
2025-11-06	ASND	199.22	90.8	420.5	-2.21
2025-11-07	ASND	197.74	90.8	416.8	-2.21
2025-11-10	ASND	196.01	90.8	416.5	-2.21
2025-11-11	ASND	201.16	90.8	423.6	-2.21
2025-11-12	ASND	200.15	90.8	417.2	-2.21
2025-11-13	ASND	206.50	90.8	424.1	-2.21
2025-11-14	ASND	204.51	93.8	376.0	-3.28
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	ASND	0.00	-3.53	4.26
2025-10-21	ASND	0.00	-3.53	4.26
2025-10-22	ASND	0.00	-3.53	4.26
2025-10-23	ASND	0.00	-3.53	4.26
2025-10-24	ASND	0.00	-3.53	4.26
2025-10-27	ASND	0.00	-3.32	5.69
2025-10-28	ASND	0.00	-3.32	5.69
2025-10-29	ASND	0.00	-3.32	5.69
2025-10-30	ASND	0.00	-3.32	5.69
2025-10-31	ASND	0.00	-3.32	5.69
2025-11-03	ASND	0.00	-3.41	5.69
2025-11-04	ASND	0.00	-3.41	5.69
2025-11-05	ASND	0.00	-3.41	5.69
2025-11-06	ASND	0.00	-3.41	5.69
2025-11-07	ASND	0.00	-3.41	5.69
2025-11-10	ASND	0.00	-5.52	5.69
2025-11-11	ASND	0.00	-5.52	5.69
2025-11-12	ASND	0.00	-5.52	5.90
2025-11-13	ASND	0.00	-5.52	5.90
2025-11-14	ASND	0.00	-5.52	5.90
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.17

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

0.29

Insider Transactions

Institutional Transactions

-5.52

Beta

0.44

Average Sales Estimate Current Quarter

236

Average Sales Estimate Next Quarter

280

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

5.5

Max Drawdown 5-Year %

-61.7

Target Price

255.17

P/E

Forward P/E

51.02

PEG

P/S

17.17

P/B

P/Free Cash Flow

EPS

-4.25

Average EPS Est. Cur. Y

-3.28

EPS Next Y. (Est.)

3.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-35.52

Relative Volume

2.38

Return on Equity vs Sector %

106.9

Return on Equity vs Industry %

121.7

EPS 1 7Days Diff

-1.1

EPS 1 30Days Diff

-0.69

EBIT Estimation

376

Ascendis Pharma A/S

Sector: Healthcare

Industry: Biotechnology

Employees: 1017

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today

news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance

stock history ASND – Ascendis Pharma A/S invest stock market

stock prices ASND premarket after hours

ticker ASND fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ASND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y